Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI

Headache

Volumn 52, Issue 2, 2012, Pages 236-243

  Tepper, Stewart J ^a   Lowe, Mark J ^a   Beall, Erik ^a   Phillips, Micheal D ^a   Liu, Kecheng ^b   Stillman, Mark J ^a   Horvat, Mary ^a   Jones, Stephen E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Siemens MR RandD Research Collaborations   (United States)

Author keywords

migraine brain iron deposition; migraine functional imaging; migraine imaging techniques; migraine progression; MRI headache imaging

Indexed keywords

IRON;

ADULT; ARTICLE; BASAL GANGLION; BRAIN LEVEL; CHRONIC DAILY HEADACHE; CHRONIC TENSION HEADACHE; CLINICAL ARTICLE; DRUG INDUCED HEADACHE; EPISODIC MIGRAINE; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERIAQUEDUCTAL GRAY MATTER; PRIMARY CHRONIC MIGRAINE; PRIORITY JOURNAL; RED NUCLEUS; VOLUNTEER;

ADULT; BRAIN; FEMALE; HEADACHE DISORDERS; HUMANS; IMAGING, THREE-DIMENSIONAL; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIGRAINE DISORDERS; YOUNG ADULT;

EID: 84857058908     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.02056.x     Document Type: Article

References (15)

1. Katsarava Z, Schneeweiss S, Kurth T, et al,. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004; 62: 788-790. (Pubitemid 38298959)
2. Scher AI, Stewart WF, Liberman J, Lipton RB,. Prevalence of frequent headache in a population sample. Headache. 1998; 38: 497-506. (Pubitemid 28429337)
3. Scher AI, Stewart WF, Ricci JA, Lipton RB,. Factors associated with the onset and remission of chronicdaily headache in a population-based study. Pain. 2003; 106: 81-89. (Pubitemid 37329617)
4. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB,. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008; 48: 1157-1168.
5. Manack A, Buse DC, Serrano D, Turkel CC, Lipton RB,. Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology. 2011; 76: 711-718.
6. OnabotulinumtoxinA US prescribing information. 2011
7. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
8. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, et al,. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-746.
9. Welch KM, Nagesh V, Aurora SK, Gelman N,. Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache. 2001; 41: 629-637. (Pubitemid 32777745)
10. Kruit MC, Launer LJ, Overbosch J, van Buchem MA, Ferrari MD,. Iron accumulation in deep brain nuclei in migraine: A population-based magnetic resonance imaging study. Cephalalgia. 2009; 29: 351-359.
11. Haacke EM, Ayaz M, Khan A, et al,. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging. 2007; 26: 256-264. (Pubitemid 47257722)
12. Haacke EM, Makki M, Ge Y, et al,. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009; 29: 537-544.
13. Weiller C, May A, Limmroth V, et al,. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995; 1: 658-660.
14. Cao Y, Welch KM, Aurora S, Vikingstad EM,. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol. 1999; 56: 548-554. (Pubitemid 29218149)
15. Knight YE, Goadsby PJ,. The periaqueductal grey matter modulates trigeminovascular input: A role in migraine? Neuroscience. 2001; 106: 793-800. (Pubitemid 33000183)